Search results for BAIAP2

Showing 17 results out of 17

×

Species

Types

Compartments

Reaction types

Search properties

Species

Types

Compartments

Reaction types

Search properties

Protein (5 results from a total of 5)

Identifier: R-HSA-442574
Species: Homo sapiens
Compartment: cytosol
Primary external reference: UniProt: BAIAP2: Q9UQB8
Identifier: R-HSA-9693276
Species: Homo sapiens
Compartment: cytosol
Primary external reference: UniProt: BAIAP2L1: Q9UHR4
Identifier: R-HSA-9693277
Species: Homo sapiens
Compartment: cytosol
Primary external reference: UniProt: BAIAP2L2: Q6UXY1
Identifier: R-HSA-8853128
Species: Homo sapiens
Compartment: plasma membrane
Primary external reference: UniProt: FGFR3: P22607
Identifier: R-HSA-8853131
Species: Homo sapiens
Compartment: plasma membrane
Primary external reference: UniProt: FGFR3: P22607

Interactor (4 results from a total of 4)

Identifier: Q9UQB8-4
Species: Homo sapiens
Primary external reference: UniProt: Q9UQB8-4
Identifier: Q9UQB8-6
Species: Homo sapiens
Primary external reference: UniProt: Q9UQB8-6
Identifier: Q9UQB8-3
Species: Homo sapiens
Primary external reference: UniProt: Q9UQB8-3
Identifier: Q765P7
Species: Homo sapiens
Primary external reference: UniProt: Q765P7

Complex (2 results from a total of 2)

Identifier: R-HSA-8853206
Species: Homo sapiens
Compartment: plasma membrane
Identifier: R-HSA-8853195
Species: Homo sapiens
Compartment: plasma membrane

Reaction (6 results from a total of 6)

Identifier: R-HSA-2029465
Species: Homo sapiens
Compartment: plasma membrane, cytosol
WASP family verprolin-homologous proteins (WAVEs) function downstream of RAC1 and are involved in activation of the ARP2/3 complex. The resulting actin polymerization mediates the projection of the plasma membrane in lamellipodia and membrane ruffles. WAVEs exist as a pentameric hetero-complex called WAVE Regulatory Complex (WRC). The WRC consists of a WAVE family protein (WASF1, WASF2 or WASF3 - commonly known as WAVE1, WAVE2 or WAVE3), ABI (Abelson-interacting protein), NCKAP1 (NAP1, p125NAP1), CYFIP1 (SRA1) or the closely related CYFIP2 (PIR121), and BRK1 (HSPC300, BRICK). Of the three structurally conserved WAVEs in mammals, the importance of WAVE2 in activation of the ARP2/3 complex and the consequent formation of branched actin filaments is best established. WAVEs in the WRC are intrinsically inactive and are stimulated by RAC1 GTPase and phosphatidylinositols (PIP3). The C-terminal VCA domain of WAVE2 (and likely WAVE1 and WAVE3) which can bind both the ARP2/3 complex and actin monomers (G-actin) is masked in the inactive state. After PIP3 binds to the polybasic region of WAVE2 (and likely WAVE1 and WAVE3) and RAC1:GTP binds to the CYFIP1 (or CYFIP2) subunit of the WRC, allosteric changes most likely occur which allow WAVEs to interact with the ARP2/3 complex. The interactions between WAVEs and RAC1 are indirect. BAIAP2/IRSp53, an insulin receptor substrate, acts as a linker, binding both activated RAC1 and the proline-rich region of WAVE2 (and likely WAVE1 and WAVE3) and forming a trimolecular complex. CYFIP1 (or CYFIP2) in the WAVE regulatory complex binds directly to RAC1:GTP and links it to WAVE2 (and likely WAVE1 and WAVE3) (Derivery et al. 2009, Yamazaki et al. 2006, Takenawa & Suetsugu 2007, Chen et al. 2010, Pollard 2007, Lebensohn & Kirschner 2009).
Identifier: R-HSA-9018808
Species: Homo sapiens
Compartment: plasma membrane, cytosol
In its active form, plasma membrane associated RAC3 binds to the following effectors:
NOX1 complex (Miyano et al. 2009)
NOX2 complex (Miyano et al. 2009)
NOX3 complex (Miyano et al. 2009)
PAK2 (Bagci et al. 2020; activation of PAK2 downstream of RAC3 was demonstrated by Mira et al. 2000, but direct binding was not tested in the study)
WAVE1 complex, through direct interaction with WASF1 (Bagci et al. 2020) and CYFIP1 (Bagci et al. 2020)
WAVE2 complex, through direct interaction with WASF2 (Bagci et al. 2020) and CYFIP1 (Bagci et al. 2020)

The following proteins are annotated as candidate RAC3 effectors because their interactions with RAC3 have not been sufficiently characterized:
ABI1 (Bagci et al. 2020)
ABI2 (Bagci et al. 2020)
ABL2 (Bagci et al. 2020)
AMIGO2 (Bagci et al. 2020)
BAIAP2 (Bagci et al. 2020)
BAIAP2L1 (Bagci et al. 2020)
BRK1 (Bagci et al. 2020)
CAV1 (Bagci et al. 2020)
CDC42 (Bagci et al. 2020)
CDC42EP1 (Bagci et al. 2020)
DEPDC1B (Bagci et al. 2020)
DIAPH3 (Bagci et al. 2020)
DSG2 (Bagci et al. 2020)
EPHA2 (Bagci et al. 2020)
ERBIN (Bagci et al. 2020)
FERMT2 (Bagci et al. 2020)
GIT1 (Bagci et al. 2020)
GIT2 (Bagci et al. 2020)
IL32 (Bagci et al. 2020)
ITGB1 (Bagci et al. 2020)
JAG1 (Bagci et al. 2020)
KIAA0355 (Bagci et al. 2020)
LAMTOR1 (Bagci et al. 2020)
MCAM (Bagci et al. 2020)
MPP7 (Bagci et al. 2020)
NCKAP1 (Bagci et al. 2020)
NHS (Bagci et al. 2020)
PAK1 (Mira et al. 2000: RAC3 induces PAK1 activation but direct interaction has not been tested)
PAK4 (Bagci et al. 2020)
RAB7A (Bagci et al. 2020)
RAPGEF1 (Bagci et al. 2020)
SLC1A5 (Bagci et al. 2020)
SLITRK3 (Bagci et al. 2020)
SLITRK5 (Bagci et al. 2020)
SNAP23 (Bagci et al. 2020)
STBD1 (Bagci et al. 2020)
SWAP70 (Bagci et al. 2020)
TAOK3 (Bagci et al. 2020)
TFRC (Bagci et al. 2020)
TMPO (Bagci et al. 2020)
VAMP3 (Bagci et al. 2020)
VANGL1 (Bagci et al. 2020)

Active RAC3 does not bind to the following established or putative RAC effectors:
ANKLE2 (Bagci et al. 2020)
ARAP2 (Bagci et al. 2020)
ARFGAP3 (Bagci et al. 2020)
ARMCX3 (Bagci et al. 2020)
CDC42EP4 (Bagci et al. 2020)
DOCK1 (Bagci et al. 2020)
DOCK5 (Bagci et al. 2020)
ELMO2 (Bagci et al. 2020)
HSPE1 (Bagci et al. 2020)
LETM1 (Bagci et al. 2020)
NDUFA5 (Bagci et al. 2020)
NDUFS3 (Bagci et al. 2020)
PLEKHG3 (Bagci et al. 2020)
PLEKHG4 (Bagci et al. 2020)
SHTM2 (Bagci et al. 2020)
STX5 (Bagci et al. 2020)
VAPB (Bagci et al. 2020)
Identifier: R-HSA-9014294
Species: Homo sapiens
Compartment: cytosol, plasma membrane
In its GTP bound active form, plasma membrane associated RAC2 binds to the following effectors:
IQGAP1 (Meng et al. 2007)
KIAA0355 (Bagci et al. 2020: interaction tested in detail)
PAK1 (Knaus et al. 1998; Hoppe and Swanson 2004; Carstanjen et al. 2005)
PAK4 (Zhang et al. 2019; Bagci et al. 2020)
PI3K alpha (Bokoch et al. 1996)
PLD2 (Peng et al. 2011)

The following candidate RAC2 effectors have so far only been reported in the high throughput screen by Bagci et al. 2020:
ABI1 (Bagci et al. 2020)
ABI2 (Bagci et al. 2020)
BAIAP2L1 (Bagci et al. 2020)
CAV1 (Bagci et al. 2020)
CDC42 (Bagci et al. 2020)
CDC42EP1 (Bagci et al. 2020)
CDC42EP4 (Bagci et al. 2020)
DEPDC1B (Bagci et al. 2020)
DIAPH3 (Bagci et al. 2020)
DSG2 (Bagci et al. 2020)
EPHA2 (Bagci et al. 2020)
ERBIN (Bagci et al. 2020)
GIT1 (Bagci et al. 2020)
GIT2 (Bagci et al. 2020)
ITGB1 (Bagci et al. 2020)
LAMTOR1 (Bagci et al. 2020)
MCAM (Bagci et al. 2020)
MPP7 (Bagci et al. 2020)
NCKAP1 (Bagci et al. 2020)
NHS (Bagci et al. 2020)
PAK2 (Bagci et al. 2020)
RAB7A (Bagci et al. 2020)
SLITRK5 (Bagci et al. 2020)
STBD1 (Bagci et al. 2020)
STX5 (Bagci et al. 2020)
SWAP70 (Bagci et al. 2020)
TAOK3 (Bagci et al. 2020)
TFRC (Bagci et al. 2020)
TMPO (Bagci et al. 2020)
VAMP3 (Bagci et al. 2020)
VANGL1 (Bagci et al. 2020)
WAVE2 regulatory complex (interacts with subunits CYFIP1 and WASF2) (Bagci et al. 2020)

RAC2 does not bind the following RHO GTPase effectors:
ABL2 (Bagci et al. 2020)
AMIGO2 (Bagci et al. 2020)
ARAP2 (Bagci et al. 2020)
ARFGAP3 (Bagci et al. 2020)
BAIAP2 (Bagci et al. 2020)
BRK1 (Bagci et al. 2020)
DOCK1 (Bagci et al. 2020)
DOCK5 (Bagci et al. 2020)
ELMO2 (Bagci et al. 2020)
FERMT2 (Bagci et al. 2020)
HSPE1 (Bagci et al. 2020)
IL32 (Bagci et al. 2020)
JAG1 (Bagci et al. 2020)
LETM1 (Bagci et al. 2020)
NDUFA5 (Bagci et al. 2020)
NDUFS3 (Bagci et al. 2020)
PLEKHG3 (Bagci et al. 2020)
PLEKHG4 (Bagci et al. 2020)
RAPGEF1 (Bagci et al. 2020)
SHMT2 (Bagci et al. 2020)
SLC1A5 (Bagci et al. 2020)
SLITRK3 (Bagci et al. 2020)
SNAP23 (Bagci et al. 2020)
WAVE1 complex subunit WASF1 (Bagci et al. 2020)
YKT6 (Bagci et al. 2020)
Identifier: R-HSA-9014449
Species: Homo sapiens
Compartment: plasma membrane
Activated GTP bound RHOG binds to the following effectors at the plasma membrane:
DOCK1 (Katoh et al. 2006, Bagci et al. 2020)
DOCK2 (Damoulakis et al. 2014)
DOCK3 (Namekata et al. 2012)
DOCK4 (Hiramoto‑Yamaki et al. 2010, Hiramoto et al. 2006, Bagci et al. 2020 )
IQGAP2 (Wennerberg et al. 2002)
MAP3K11 (Wennerberg et al. 2002)
PLEKHG3 (Bagci et al. 2020)
PLD1 (Wennerberg et al. 2002)

The following candidate effectors that localize to the plasma membrane or cytosol have been found to bind to active RHOG in the high throughput screen by Bagci et al. 2020:
ARFGAP3 (Bagci et al. 2020)
CAV1 (Bagci et al. 2020)
CDC42 (Bagci et al. 2020)
CDC42EP1 (Bagci et al. 2020)
CYFIP1 (Bagci et al. 2020)
DEPDC1B (Bagci et al. 2020)
DIAPH3 (Bagci et al. 2020)
DOCK5 (Bagci et al. 2020)
DSG2 (Bagci et al. 2020)
ELMO2 (Bagci et al. 2020)
EPHA2 (Bagci et al. 2020)
ERBIN (Bagci et al. 2020)
HSPE1 (Bagci et al. 2020)
ITGB1 (Bagci et al. 2020)
KIAA0355 (Bagci et al. 2020)
LAMTOR1 (Bagci et al. 2020)
MCAM (Bagci et al. 2020)
MPP7 (Bagci et al. 2020)
NDUFA5 (Bagci et al. 2020)
NDUFS3 (Bagci et al. 2020)
PAK2 (Bagci et al. 2020)
PAK4 (Bagci et al. 2020)
RAB7A (Bagci et al. 2020)
SHMT2 (Bagci et al. 2020)
STBD1 (Bagci et al. 2020)
TFRC (Bagci et al. 2020)
TMPO (Bagci et al. 2020)
VAMP3 (Bagci et al. 2020)
VANGL1 (Bagci et al. 2020)

Activated RHOG does not act on or does not bind to the following putative effectors in the high throughput screen by Bagci et al. 2020:
ABI1 (Bagci et al. 2020)
ABI2 (Bagci et al. 2020)
ABL2 (Bagci et al. 2020)
AMIGO2 (Bagci et al. 2020)
ARAP2 (Bagci et al. 2020)
ARMCX3 (Bagci et al. 2020)
BAIAP2 (Wennerberg et al. 2002, Bagci et al. 2020)
BAIAP2L1 (Bagci et al. 2020)
BRK1 (Bagci et al. 2020)
CDC42EP4 (Bagci et al. 2020)
FERMT2 (Bagci et al. 2020)
GIT1 (Bagci et al. 2020)
GIT2 (Bagci et al. 2020)
IL32 (Bagci et al. 2020)
JAG1 (Bagci et al. 2020)
NCKAP1 (Bagci et al. 2020)
NHS (Bagci et al. 2020)
PAK1 (Wennerberg et al. 2002)
PAK5 (Wennerberg et al. 2002)
PAK6 (Wennerberg et al. 2002)
PARD6A (Wennerberg et al. 2002)
PLEKHG4 (Bagci et al. 2020)
RAPGEF1 (Bagci et al. 2020)
SLC1A5 (Bagci et al. 2020)
SLITRK3 (Bagci et al. 2020)
SLITRK5 (Bagci et al. 2020)
SNAP23 (Bagci et al. 2020)
SWAP70 (Bagci et al. 2020)
TAOK3 (Bagci et al. 2020)
WAS (WASP) (Wennerberg et al. 2002)
WASF1 (Bagci et al. 2020)
WASF2 (Bagci et al. 2020)

Activated RHOG interacts with the WAVE complex component CYFIP1 (Bagci et al. 2020), but not with the WAVE complex components WASF1 and WASF2 (Bagci et al. 2020). The WAVE complex is not annotated as a RHOG effector.
Identifier: R-HSA-9013157
Species: Homo sapiens
Compartment: plasma membrane, cytosol
In its GTP bound active form, plasma membrane associated CDC42 binds to the following effectors:
BAIAP2 (Krugmann et al. 2001; Kast et al. 2014)
CDC42BPA (also known as MRCK alpha or MRCKA) (Leung et al. 1998; Schwarz et al. 2012; Bagci et al. 2020)
CDC42BPB (also known as MRCK beta or MRCKB) (Zihni et al. 2017; Bagci et al. 2020)
CDC42EP1 (also known as Borg5) (Joberty et al. 1999; Bagci et al. 2020)
CDC42EP2 (also known as Borg1) (Joberty et al. 1999; Bagci et al. 2020)
CDC42EP3 (also known as Borg2) (Joberty et al. 1999)
CDC42EP4 (also known as Borg4) (Joberty et al. 1999; Bagci et al. 2020)
CDC42EP5 (also known as Borg3) (Joberty et al. 1999)
FMNL1 (Kuhn et al. 2015)
FMNL2 (Block et al. 2012; Kuhn et al. 2015)
FMNL3 (Richards et al. 2015)
FNBP1 (also known as FBP17) (Chan Wah Hak et al. 2018; Bagci et al. 2020)
FNBP1L (also known as Toca-1) (Ho et al. 2004; Bagci et al. 2020)
IQGAP1 (Hart et al. 1996; Kuroda et al. 1996; Swart Mataraza et al. 2002)
IQGAP2 (Brill et al. 1996)
MAP3K11 (Leung and Lassam 1998)
PAK1 (Parrini et al. 2002; Bagci et al. 2020)
PAK2 (Wu and Wang 2003; Bagci et al. 2020)
PAK3 (Rousseau et al. 2003)
PAK5 (Dan et al. 2002; Ching et al. 2003, Wu and Frost 2006)
PAK6 (Lee et al. 2002, Morse et al. 2016)
PAK7 (Amado Azevedo et al. 2017)
PARD6A (Qiu et al. 2000)
PLD1 (Hammond et al. 1997)
WASP complex, through interaction with WASP complex components WASL (Kim et al. 2000; Bagci et al. 2020), WAS (WASP) (Aspenstrom et al. 1996), WIPF1 (also known as WIP) (Ramesh et al. 1997), WIPF2 (Bagci et al. 2020) and WIPF3 (Bagci et al. 2020)

The following putative CDC42 effectors are annotated as candidates either because of the opposing findings reported by different studies or because they have only been reported in the high throughput screen by Bagci et al. 2020 as proteins that bind to constitutively active CDC42 mutant:
ARFGAP2 (Bagci et al. 2020)
ARFGAP3 (Bagci et al. 2020)
ARHGAP1 (Bagci et al. 2020)
ARHGEF7 (Bagci et al. 2020)
CAV1 (Bagci et al. 2020)
CDC42SE2 (Bagci et al. 2020)
CPNE8 (Bagci et al. 2020)
DAAM1 (Aspenstrom et al. 2006: binding to active CDC42; Higashi et al. 2008: no binding to active CDC42)
DEPDC1B (Bagci et al. 2020)
DIAPH3 (Bagci et al. 2020)
GIT1 (Bagci et al. 2020)
GIT2 (Bagci et al. 2020)
GOLGA8R (Bagci et al. 2020)
IQGAP3 (Wang et al. 2007: binding to active CDC42; Bagci et al. 2020: no binding to active CDC42)
JUP (Bagci et al. 2020)
KCTD3 (Bagci et al. 2020)
LAMTOR1 (Bagci et al. 2020)
PAK4 (Bagci et al. 2020)
RAB7A (Bagci et al. 2020)
SCRIB (Bagci et al. 2020)
SH3PXD2A (Bagci et al. 2020)
SHKBP1 (Bagci et al. 2020)
SNAP23 (Bagci et al. 2020)
STEAP3 (Bagci et al. 2020)
STOM (Bagci et al. 2020)
TFRC (Bagci et al. 2020)
TMPO (Bagci et al. 2020)
VAMP3 (Bagci et al. 2020)
VANGL1 (Bagci et al. 2020)
WDR81 (Bagci et al. 2020)
WDR91 (Bagci et al. 2020)

CDC42 does not bind the following RHO GTPase effectors:
ARL13B (Bagci et al. 2020)
DIAPH1 (Higashi et al. 2008)
GFOD1 (Bagci et al. 2020)
GJA1 (Bagci et al. 2020)
KIAA0355 (Bagci et al. 2020)
MPP7 (Bagci et al. 2020)
NIPSNAP2 (Bagci et al. 2020)
PLEKHG3 (Bagci et al. 2020)
ROCK1 (Leung et al. 1996)
ROCK2 (Leung et al. 1996)
RTKN (Reid et al. 1996)
SLC1A5 (Bagci et al. 2020)
SLC4A7 (Bagci et al. 2020)
SLK (Yamada et al. 2000)
WASF1 (Miki et al. 1998) – component of the WAVE1 complex
WWP2 (Bagci et al. 2020)
Identifier: R-HSA-9013145
Species: Homo sapiens
Compartment: plasma membrane, cytosol
In its GTP bound active form, plasma membrane associated RAC1 binds to the following cytosolic and plasma membrane effectors:
BAIAP2 (Lewis Saravalli et al. 2013, Bagci et al. 2020)
CAV1 (Nethe et al. 2010, Bagci et al. 2020)
CDC42BPA (Schwarz et al. 2012)
CIT (Madaule et al. 1995)
CIT 3 (Di Cunto et al. 1998)
CYFIP1 (Schneck et al. 2003, Bagci et al. 2020)
FMNL1 (Yayoshi Yamamoto et al. 2000)
IQGAP1 (Kuroda et al. 1996, Pelikan Conchaudron et al. 2011)
IQGAP2 (Brill et al. 1996, Ozdemir et al. 2018)
IQGAP3 (Wang et al. 2007)
KIAA0355 (Bagci et al. 2020: interaction studied in detail)
NISCH (Reddig et al. 2005)
NOX1 complex (Cheng et al. 2006, Miyano et al. 2006, Kao et al. 2008)
NOX2 complex (Price et al. 2002)
NOX3 complex (Ueyama et al. 2006, Miyano and Sumimoto 2007, Kao et al. 2008)
PAK1 (Parrini et al. 2002)
PAK2 (Manser et al. 1994, Manser et al. 1995, Bagci et al. 2020)
PAK3 (Manser et al. 1995)
PAK4 (Abo et al. 1998, Bagci et al. 2020)
PAK5 (Dan et al. 2002)
PAK6 (Lee et al. 2002)
PARD6A (Qiu et al. 2000)
PI3K alpha (Bokoch et at al. 1996, Murga et al. 2002)
PKN1 (Owen et al. 2003, Modha et al. 2008)
PKN2 (Zong et al. 1999)
PLD1 (Hammond et al. 1997)
PLD2 (Hiroyama and Exton 2005)
WAVE complex (Miki et al. 1998, Suetsugu et al. 2006, Bagci et al. 2020)

The following RAC1 effectors are annotated as candidate effectors either because of opposing finding reported in different studies or because they have only been reported in the high throughput screen by Bagci et al. 2020:
ABI1 (Bagci et al. 2020)
ABL2 (Bagci et al. 2020)
AMIGO2 (Bagci et al. 2020)
ARAP2 (Bagci et al. 2020)
BAIAP2L1 (Bagci et al. 2020)
BRK1 (Bagci et al. 2020)
CDC42 (Bagci et al. 2020)
CDC42EP1 (Bagci et al. 2020: binding to activated RAC1; Joberty et al. 1999: no binding to activated RAC1)
CDC42EP4 (Bagci et al. 2020: binding to activated RAC1; Joberty et al. 1999: no binding to activated RAC1)
DEPDC1B (Bagci et al. 2020)
DIAPH3 (Bagci et al. 2020)
EPHA2 (Bagci et al. 2020)
ERBIN (Bagci et al. 2020)
FERMT2 (Bagci et al. 2020)
GIT1 (Bagci et al. 2020)
GIT2 (Bagci et al. 2020)
ITGB1 (Bagci et al. 2020)
JAG1 (Bagci et al. 2020)
LAMTOR1 (Bagci et al. 2020)
MCAM (Bagci et al. 2020)
MPP7 (Bagci et al. 2020)
NCKAP1 (Bagci et al. 2020)
NHS (Bagci et al. 2020)
PLEKHG3 (Bagci et al. 2020)
PLEKHG4 (Bagci et al. 2020)
RAB7A (Bagci et al. 2020)
SLC1A5 (Bagci et al. 2020)
SNAP23 (Bagci et al. 2020)
SWAP70 (Bagci et al. 2020)
TAOK3 (Bagci et al. 2020)
TFRC (Bagci et al. 2020)
TMPO (Bagci et al. 2020)
VAMP3 (Bagci et al. 2020)
VANGL1 (Bagci et al. 2020)
WIP WASP complex (WAS, also known as WASP, a component of the WIP WASP complex, was reported to interact with active RAC1 by Aspenstrom et al. 1996 and Vastrik et al. 1999, but no interaction has been reported between RAC1 and WIP components of the complex, WIPF1, WIPF2 or WIPF3)

Active RAC1 does not bind the following RHO GTPase effectors:
ANKLE2 (Bagci et al. 2020)
ARFGAP3 (Bagci et al. 2020)
ARMCX3 (Bagci et al. 2020)
CDC42EP2 (Joberty et al. 1999)
CDC42EP3 (Joberty et al. 1999)
CDC42EP5 (Joberty et al. 1999)
DSG2 (Bagci et al. 2020)
DIAPH1 (Higashi et al. 2008)
DOCK1 (Bagci et al. 2020)
DOCK5 (Bagci et al. 2020)
ELMO2 (Bagci et al. 2020)
FMNL2 (Block et al. 2012)
HSPE1 (Bagci et al. 2020)
IL32 (Bagci et al. 2020)
LETM1 (Bagci et al. 2020)
LMAN1 (Bagci et al. 2020)
NDUFA5 (Bagci et al. 2020)
NDUFS3 (Bagci et al. 2020)
PGRMC2 (Bagci et al. 2020)
RAPGEF1 (Bagci et al. 2020)
ROCK1 (Leung et al. 1996)
ROCK2 (Leung et al. 1996)
RTKN (Reid et al. 1996)
SHMT2 (Bagci et al. 2020)
SLK (Yamada et al. 2000)
SLITRK3 (Bagci et al. 2020)
SLITRK5 (Bagci et al. 2020)
STBD1 (Bagci et al. 2020)
STX5 (Bagci et al. 2020)
VAPB (Bagci et al. 2020)
Cite Us!